Stay updated on Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.

Latest updates to the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page
- Check4 days agoChange DetectedThe page now indicates that recruitment has ended, and the navigation/section headings have been expanded to include How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment label, along with a revision update to v3.6.0.SummaryDifference0.1%

- Check11 days agoChange DetectedA new page revision tag, Revision: v3.5.5, was added to replace Revision: v3.5.4, signaling a minor update to the page's version metadata.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry, v3.5.4, was added, replacing the previous v3.5.3 in the page's revision history.SummaryDifference0.0%

- Check47 days agoChange DetectedTaoyuan District, Taiwan, 333 has been replaced with Taoyuan, Taiwan, 333 in the study's locations list. This updates the site naming to reflect the current Taoyuan location used for the trial.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s system revision/version indicator was updated from v3.5.2 to v3.5.3 with no visible change to the study details content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.